IDEXX beats ‘the Street’ on Q4 results, issues ’23 outlook

IDEXX Laboratories Inc. (NASDAQ) on Monday posted fourth-quarter earnings and revenues that beat estimates and issued a bullish initial outlook for 2023. 

The Westbroook-based provider of veterinary diagnostics, veterinary practice software and water testing reported earnings of $2.05 per share for the quarter that ended Dec. 31, beating the $1.92 per share consensus estimate of analysts polled by Zacks Investment Research. The figure compares to $1.89 per share for the third quarter of 2022. Read more

Related Posts

UNE receives $10.8 million to establish new Center for Cell Signaling Research

The University of New England has received a five-year, $10.8 million award from the National Institutes of Health to support an...

18 January 2024

Jackson Lab opens $4.5M on-site child care center in Bar Harbor

Anewly constructed child care center on the Jackson Laboratory’s Bar Harbor campus is seen as an important draw for employees that also...

17 January 2024

From med tech to skin care: Top Gun names 41 startups to 2024 lineup

Out of 57 companies that applied to Maine’s 2024 Top Gun business accelerator program, 41 have been accepted and will receive help...

16 January 2024